OTCM
NEPTF
Market cap0kUSD
May 29, Last price
0.00USD
Name
Neptune Wellness Solutions Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Neptune Wellness Solutions Inc. functions as an all-encompassing health and wellness company, with operations spanning Canada, the United States, and various international regions. The firm actively develops and markets its own collection of consumer lifestyle brands and packaged goods, including names such as Biodroga, Forest Remedies, Ocean Remedies, Neptune Wellness, Mood Ring, PanHash, Sprout, Nosh, MaxSimil, and NurturMe. Beyond its proprietary brands, Neptune offers complete product development and supply chain services to corporate clients across diverse health and wellness sectors, which encompass nutraceuticals, beauty and personal care items, and organic food and beverage products. The company is also proficient in the entire process of producing health and wellness goods, from initial extraction and purification to final formulation and manufacturing. A significant innovation from Neptune is MaxSimil, an advanced delivery system for omega-3 fatty acids. This technology employs enzymes that mimic the natural human digestive system to pre-digest omega-3s, thereby improving their absorption. Furthermore, the company has forged a partnership with International Flavors & Fragrances Inc. to jointly create hemp-derived CBD products specifically for the mass retail and wider health and wellness markets. Established in 1998, Neptune Wellness Solutions Inc. is headquartered in Laval, Canada.
Key people
Mario Paradis
Chief Financial Officer · since 2015
Chief Financial Officer · since 2020
Senior Vice President of Sales - Global Sales · since 2013
Brett DuBose
Vice President of Sales, U.S. Region · since 2019
Martin Landry
Chief of Corporate Development and Strategy · since 2019
Chief Operating Officer of Acasti
Graham Keith Wood
Chief Scientific Officer · since 2019
Corporate Secretary and Director - Corporate Affairs · since 2014
Helene F. Fortin
Director · since 2018
John Moretz
Chairman of the Board · since 2017
Ronald Denis
Independent Director · since 2014
Independent Director · since 2014
Independent Director · since 2013
Jerald J. Wenker
Independent Director · since 2014
Headquarters & legal address
545 Promenade du Centropolis
Suite 100
Laval, QC H7T 0A3
CA
Suite 100
Laval, QC H7T 0A3
CA
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||